Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
Singh, D., Onyeagucha, B. C., Medina, D., Subbarayalu, P., Mojidra, R., Lyu, D., Bhandari, M., Timilsina, S., Pitta Venkata, P., Huang, J. Y., Nirzhor, S., Abdulsahib, S., Prochnau, J. Y., Do, C. T. P., Rajamanickam, S., Chen, Y., Taylor, A. B., Viswanadhapalli, S., Falzone, M. & Jiang, J. X. & 5 others, , Mar 2 2026, In: Cancer Research. 86, 5, p. 1252-1268 17 p.Research output: Contribution to journal › Article › peer-review
-
Epigenetic silencing of DNA sensing pathway by FOXM1 blocks stress ligand-dependent antitumor immunity and immune memory
Timilsina, S., Huang, J. Y., Abdelfattah, N., Medina, D., Singh, D., Abdulsahib, S., Subbarayalu, P., Do, T. P., Venkata, P. P., Nirzhor, S., Prochnau, J., Bhandari, M., Zheng, S., Chen, Y., Huang, G., Mukherjee, N., Hromas, R., Sung, P., Kaklamani, V. & Vadlamudi, R. & 2 others, , Dec 2025, In: Nature communications. 16, 1, 3967.Research output: Contribution to journal › Article › peer-review
Open Access7 Link opens in a new tab Scopus citations -
Targeting DDR2 for Treating Pancreatic Cancer
Do, C. T. P., Venkata, P. P., Prochnau, J. Y., Singh, D., Timilsina, S., Subbarayalu, P., Medina, D., Abdulsahib, S., Nirzhor, S., Khan, S., Li, G., Polusani, S. R., Zhou, D., Wang, P., Chen, Y., Vadlamudi, R. K., Hart, M. J., Amaradhi, R., McHardy, S. F. & Rao, M. K., Oct 1 2025, In: Molecular cancer therapeutics. 24, 10, p. 1570-1583 14 p.Research output: Contribution to journal › Article › peer-review
-
Targeting the Leukemia Inhibitory Factor/Leukemia Inhibitory Factor Receptor Axis Reduces the Growth of Inflammatory Breast Cancer by Promoting Ferroptosis
Romo, B., Fuentes, Z., Randolph, L., Mahajan, M., Aller, E. J., Ebrahimi, B., Santhamma, B., Pratap, U. P., Subbarayalu, P., Nagandla, H., Thomas, C., Nair, H. B., Vadlamudi, R. K. & Viswanadhapalli, S., Mar 2025, In: Cancers. 17, 5, 790.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer
Mahajan, M., Rodriguez Sanchez, A. L., Jayamohan, S., Vijayan, D. K., Johnson, J. D., Xie, H., Wang, Y., Liang, D., Sanchez, J. R., Subbarayalu, P., Rao, M. K., Vadlamudi, R. K., Sareddy, G. R., Nair, H. B. & Viswanadhapalli, S., Sep 1 2025, In: Molecular cancer therapeutics. 24, 9, p. 1308-1319 12 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Scopus citations
Datasets
-
Imipramine Blue: A potent therapeutic regimen that suppresses breast cancer growth and metastasis
Rajamanickam, S. (Contributor), Panneerdoss, S. (Contributor), Gorthi, A. (Contributor), Timilsina, S. (Contributor), Onyeagucha, B. (Contributor), Kovalskyy, D. (Contributor), Ivanov, D. (Contributor) & Chen, Y. (Contributor), ArrayExpress, 2016
https://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-72363
Dataset
-
Androgen-Responsive microRNAs in mouse Sertoli Cells
Panneerdoss, S. (Contributor), Shetty, G. (Contributor), Wang, H. (Contributor) & Chen, Y. (Contributor), ArrayExpress, 2012
https://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-37679
Dataset